Literature DB >> 23690449

Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.

Jill M Johnsen1, Paul L Auer, Alanna C Morrison, Shuo Jiao, Peng Wei, Jeffrey Haessler, Keolu Fox, Sean R McGee, Joshua D Smith, Christopher S Carlson, Nicholas Smith, Eric Boerwinkle, Charles Kooperberg, Deborah A Nickerson, Stephen S Rich, David Green, Ulrike Peters, Mary Cushman, Alex P Reiner.   

Abstract

Several rare European von Willebrand disease missense variants of VWF (including p.Arg2185Gln and p.His817Gln) were recently reported to be common in apparently healthy African Americans (AAs). Using data from the NHLBI Exome Sequencing Project, we assessed the association of these and other VWF coding variants with von Willebrand factor (VWF) and factor VIII (FVIII) levels in 4468 AAs. Of 30 nonsynonymous VWF variants, 6 were significantly and independently associated (P < .001) with levels of VWF and/or FVIII. Each additional copy of the common VWF variants encoding p.Thr789Ala or p.Asp1472His was associated with 6 to 8 IU/dL higher VWF levels. The VWF variant encoding p.Arg2185Gln was associated with 7 to 13 IU/dL lower VWF and FVIII levels. The type 2N-related VWF variant encoding p.His817Gln was associated with 17 IU/dL lower FVIII level but normal VWF level. A novel, rare missense VWF variant that predicts disruption of an O-glycosylation site (p.Ser1486Leu) and a rare variant encoding p.Arg2287Trp were each associated with 30 to 40 IU/dL lower VWF level (P < .001). In summary, several common and rare VWF missense variants contribute to phenotypic differences in VWF and FVIII among AAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23690449      PMCID: PMC3724194          DOI: 10.1182/blood-2013-02-485094

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.

Authors:  J Eikenboom; L Hilbert; A S Ribba; A Hommais; D Habart; S Messenger; A Al-Buhairan; A Guilliatt; W Lester; C Mazurier; D Meyer; E Fressinaud; U Budde; K Will; R Schneppenheim; T Obser; O Marggraf; E Eckert; G Castaman; F Rodeghiero; A B Federici; J Batlle; J Goudemand; J Ingerslev; S Lethagen; F Hill; I Peake; A Goodeve
Journal:  J Thromb Haemost       Date:  2009-06-30       Impact factor: 5.824

3.  Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.

Authors:  Marco Campos; Wei Sun; Fuli Yu; Maja Barbalic; Weihong Tang; Lloyd E Chambless; Kenneth K Wu; Christie Ballantyne; Aaron R Folsom; Eric Boerwinkle; Jing-Fei Dong
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

4.  Evolution and functional impact of rare coding variation from deep sequencing of human exomes.

Authors:  Jacob A Tennessen; Abigail W Bigham; Timothy D O'Connor; Wenqing Fu; Eimear E Kenny; Simon Gravel; Sean McGee; Ron Do; Xiaoming Liu; Goo Jun; Hyun Min Kang; Daniel Jordan; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; Goncalo Abecasis; David Altshuler; Deborah A Nickerson; Eric Boerwinkle; Shamil Sunyaev; Carlos D Bustamante; Michael J Bamshad; Joshua M Akey
Journal:  Science       Date:  2012-05-17       Impact factor: 47.728

5.  Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study.

Authors:  P L Lutsey; M Cushman; L M Steffen; D Green; R G Barr; D Herrington; P Ouyang; A R Folsom
Journal:  J Thromb Haemost       Date:  2006-09-26       Impact factor: 5.824

6.  The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.

Authors:  P A Kroner; P A Foster; S A Fahs; R R Montgomery
Journal:  Blood       Date:  1996-02-01       Impact factor: 22.113

7.  Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.

Authors:  Karl C Desch; Ayse B Ozel; David Siemieniak; Yossi Kalish; Jordan A Shavit; Courtney D Thornburg; Anjali A Sharathkumar; Caitlin P McHugh; Cathy C Laurie; Andrew Crenshaw; Daniel B Mirel; Yoonhee Kim; Cheryl D Cropp; Anne M Molloy; Peadar N Kirke; Joan E Bailey-Wilson; Alexander F Wilson; James L Mills; John M Scott; Lawrence C Brody; Jun Z Li; David Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

8.  Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.

Authors:  Nicholas L Smith; Ming-Huei Chen; Abbas Dehghan; David P Strachan; Saonli Basu; Nicole Soranzo; Caroline Hayward; Igor Rudan; Maria Sabater-Lleal; Joshua C Bis; Moniek P M de Maat; Ann Rumley; Xiaoxiao Kong; Qiong Yang; Frances M K Williams; Veronique Vitart; Harry Campbell; Anders Mälarstig; Kerri L Wiggins; Cornelia M Van Duijn; Wendy L McArdle; James S Pankow; Andrew D Johnson; Angela Silveira; Barbara McKnight; Andre G Uitterlinden; Nena Aleksic; James B Meigs; Annette Peters; Wolfgang Koenig; Mary Cushman; Sekar Kathiresan; Jerome I Rotter; Edwin G Bovill; Albert Hofman; Eric Boerwinkle; Geoffrey H Tofler; John F Peden; Bruce M Psaty; Frank Leebeek; Aaron R Folsom; Martin G Larson; Timothy D Spector; Alan F Wright; James F Wilson; Anders Hamsten; Thomas Lumley; Jacqueline C M Witteman; Weihong Tang; Christopher J O'Donnell
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

9.  Genomic dark matter: the reliability of short read mapping illustrated by the genome mappability score.

Authors:  Hayan Lee; Michael C Schatz
Journal:  Bioinformatics       Date:  2012-06-04       Impact factor: 6.937

10.  Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants.

Authors:  Wenqing Fu; Timothy D O'Connor; Goo Jun; Hyun Min Kang; Goncalo Abecasis; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; David Altshuler; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Joshua M Akey
Journal:  Nature       Date:  2012-11-28       Impact factor: 49.962

View more
  36 in total

1.  Group association test using a hidden Markov model.

Authors:  Yichen Cheng; James Y Dai; Charles Kooperberg
Journal:  Biostatistics       Date:  2015-09-28       Impact factor: 5.899

Review 2.  Massively parallel sequencing: the new frontier of hematologic genomics.

Authors:  Jill M Johnsen; Deborah A Nickerson; Alex P Reiner
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

3.  A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice.

Authors:  Andrew Yee; Robert D Gildersleeve; Shufang Gu; Colin A Kretz; Beth M McGee; Keisha M Carr; Steven W Pipe; David Ginsburg
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

4.  The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.

Authors:  Veronica H Flood; Jessica Garcia; Sandra L Haberichter
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

Review 5.  Laboratory diagnosis of von Willebrand disease.

Authors:  J C Roberts; V H Flood
Journal:  Int J Lab Hematol       Date:  2015-05       Impact factor: 2.877

6.  Whole-exome imputation of sequence variants identified two novel alleles associated with adult body height in African Americans.

Authors:  Mengmeng Du; Paul L Auer; Shuo Jiao; Jeffrey Haessler; David Altshuler; Eric Boerwinkle; Christopher S Carlson; Cara L Carty; Yii-Der Ida Chen; Keith Curtis; Nora Franceschini; Li Hsu; Rebecca Jackson; Leslie A Lange; Guillaume Lettre; Keri L Monda; Deborah A Nickerson; Alex P Reiner; Stephen S Rich; Stephanie A Rosse; Jerome I Rotter; Cristen J Willer; James G Wilson; Kari North; Charles Kooperberg; Nancy Heard-Costa; Ulrike Peters
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

7.  Guidelines for Large-Scale Sequence-Based Complex Trait Association Studies: Lessons Learned from the NHLBI Exome Sequencing Project.

Authors:  Paul L Auer; Alex P Reiner; Gao Wang; Hyun Min Kang; Goncalo R Abecasis; David Altshuler; Michael J Bamshad; Deborah A Nickerson; Russell P Tracy; Stephen S Rich; Suzanne M Leal
Journal:  Am J Hum Genet       Date:  2016-09-22       Impact factor: 11.025

8.  Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells.

Authors:  Sarah L King; Hiren J Joshi; Katrine T Schjoldager; Adnan Halim; Thomas D Madsen; Morten H Dziegiel; Anders Woetmann; Sergey Y Vakhrushev; Hans H Wandall
Journal:  Blood Adv       Date:  2017-02-23

9.  The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance.

Authors:  Ahmad H Mufti; Kenichi Ogiwara; Laura L Swystun; Jeroen C J Eikenboom; Ulrich Budde; Wilma M Hopman; Christer Halldén; Jenny Goudemand; Ian R Peake; Anne C Goodeve; David Lillicrap; Daniel J Hampshire
Journal:  Blood Adv       Date:  2018-07-10

10.  Deciphering the Roles of N-Glycans on Collagen-Platelet Interactions.

Authors:  Christian Toonstra; Yingwei Hu; Hui Zhang
Journal:  J Proteome Res       Date:  2019-05-15       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.